We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Chart Review of Outcome of Treatment for S. Aureus Bacteremia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00304902
Recruitment Status : Completed
First Posted : March 20, 2006
Last Update Posted : September 10, 2010
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to review medical records at MEDVAMC in order to relate the outcome of bacteremic MRSA infection to the antibiotics selected for treatment.

Condition or disease
Staphylococcus Aureus

  Show Detailed Description

Study Design

Study Type : Observational
Actual Enrollment : 120 participants
Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Retrospective Chart Review of the Outcome of Treatment for Staphylococcus Aureus Bacteremia
Study Start Date : February 2006
Primary Completion Date : July 2010
Study Completion Date : August 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients with Staphylococcus aureus in a blood culture.

Inclusion Criteria:

  • Patients with Staphylococcus aureus in a blood culture between January 1, 2004 and December 31, 2005.

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00304902

United States, Texas
Michael E. DeBakey Veterans Affairs Medical Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
VA Medical Center, Houston
Baylor College of Medicine
Principal Investigator: Daniel M Musher, M.D. Baylor College of Medicine, Houston VA Medical Center
More Information

Responsible Party: Nancy Logan, MA, VAMC
ClinicalTrials.gov Identifier: NCT00304902     History of Changes
Other Study ID Numbers: H-18867
First Posted: March 20, 2006    Key Record Dates
Last Update Posted: September 10, 2010
Last Verified: September 2010

Keywords provided by VA Medical Center, Houston:
Methicillin Resistant Staphylococcus aureus
Staphylococcus aureus Bacteremia

Additional relevant MeSH terms:
Bacterial Infections
Systemic Inflammatory Response Syndrome
Pathologic Processes